Lucy Marshall

Lucy works in the Life Sciences team, with a focus on biotechnological inventions such as therapeutic antibodies, immunomodulators, gene therapies and diagnostic methods. Lucy has experience in drafting patent specifications and handles the global prosecution of patent and SPC portfolios. She has also been involved in EPO oppositions and appeals, and freedom-to-operate projects.

Lucy joined Carpmaels & Ransford in 2020 after completing her PhD in neuroscience at King’s College London. Prior to this, she graduated from Imperial College London with a first class bachelor’s degree in Biochemistry.

During her undergraduate degree, Lucy completed a year’s industrial placement at Eli Lily, where she researched tau pathology in Alzheimer’s disease.  In her final year, she completed a research project using drosophila to investigate redox metabolism and ageing. She graduated with a Dean’s list award for academic excellence.

For her postgraduate studies, Lucy was awarded funding through the Wellcome Trust Cell Therapies and Regenerative Medicine MRes/PhD studentship. During her first year, Lucy took the opportunity to explore different areas of research and completed projects in stem cell regeneration, cell therapies for treatment of diabetes, and immunomodulation of spinal cord injury. Lucy chose to pursue her PhD research in spinal cord injury, where she used proteomics to identify bioactive mediators in immune and extracellular matrix interactions.

In her free time, Lucy is a keen runner and has completed several marathons. She loves to travel and has visited countries all over the world.